Novel AI model enhances diagnosis of plaque erosion in patients with acute coronary syndromes
South Korea: A newly developed "transformer"-based DL (deep learning) model may help cardiologists accurately diagnose plaque erosion in patients with acute coronary syndromes (ACS), according to a recent study published in JACC: Cardiovascular Interventions.
In recent years, a concept that the underlying pathophysiology in some patients with acute coronary syndromes could be plaque erosion rather than plaque rupture has emerged. ACS caused by plaque erosion could be managed conservatively (reduction of thrombus burden followed by aggressive medical management with anti-platelet and lipid-lowering therapy) without stenting. However, this concept still needs to be fully supported by trial evidence.
Plaque erosion diagnosis requires expertise in OCT (optical coherence tomographic) image interpretation. In addition, the current DL approaches for OCT image interpretation are based on a single frame without information integration from adjacent frames. The key to furthering this concept is to recognise plaque erosion more easily in the acute clinical setting.
In the study, Sangjoon Park from the Korea Advanced Institute of Science and Technology in Daejeon, South Korea, and colleagues deployed a deep learning approach (called a "Transformer") that enables recapitulating to some degree the human method but incorporating information from multiple frames, and facilitate an accurate diagnosis of plaque erosion.
The novel "Transformer"-based DL model integrates information from adjacent frames emulating the cardiologists who review consecutive OCT frames to make a diagnosis and compare it with the standard CNN (convolutional neural network) DL model.
The researchers used a total of 237,021 cross-sectional OCT images from 581 patients for training and internal validation, and for external validation, 65,394 images from 292 patients from another dataset were used. Model performances were evaluated using AUC (area under the receiver-operating characteristic curve).
The study led to the following findings:
- For the frame-level diagnosis of plaque erosion, the Transformer model performed better than the CNN model, with an AUC of 0.94 compared with 0.85 in the external validation.
- For the lesion-level diagnosis, the Transformer model showed improved diagnostic performance compared with the CNN model, with an AUC of 0.91 compared with 0.84 in the external validation.
The results revealed that the novel transformer-based DL model could help in the accurate diagnosis of plaque erosion in patients with acute coronary syndromes and aid clinical decision-making -- making on potential conservative management without stenting in these patients.
Identifying plaque erosion reliably is an initial step to standing-up trials testing the hypotheses developed around more conservative non-interventional therapy. How this interesting automated approach performs when deployed more broadly will be of great interest.
Reference:
Park S, Araki M, Nakajima A, Lee H, Fuster V, Ye JC, Jang IK. Enhanced Diagnosis of Plaque Erosion by Deep Learning in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2022 Oct 24;15(20):2020-2031. doi: 10.1016/j.jcin.2022.08.040. PMID: 36265933.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.